Azenta, Inc. provided earnings guidance for the full fiscal year 2024. The company expected revenue in the range of $659 million to $671 million, due to the timing of B Medical revenue.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
50.27 USD | -1.45% | -2.08% | -22.83% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-22.83% | 2.71B | |
+64.92% | 62.86B | |
-1.85% | 41.38B | |
+45.89% | 40.38B | |
-8.93% | 27.64B | |
+13.05% | 26.46B | |
-21.96% | 18.9B | |
+4.21% | 12.67B | |
+25.74% | 12.27B | |
+27.42% | 12.07B |
- Stock Market
- Equities
- AZTA Stock
- News Azenta, Inc.
- Azenta, Inc. Provides Earnings Guidance for the Full Fiscal Year 2024